Skip to main content
. 2022 Jun 21;6(3):100043. doi: 10.1016/j.shj.2022.100043

Table 2.

Functional and echocardiographic outcomes immediately after procedure and throughout follow-up

Patients, N = 16 Preprocedural Immediately/in-hospital 3-Mo after procedure 6-Mo after procedure
Functional outcome
 Invasive LAP (mmHg) 44.38 ± 6.26 18.25 ± 3.85 (p < 0.001)
 NYHA-FC III-IV 16 (100%) 1 (6.25%) 1 (6.25%) 1 (6.25%)
 Extubation in d 0 16 (100%)
 ICU stay (d)
 1 d 13 (81.25%)
 2 d 3 (18.75%)
 Total in-hospital stay (d)
 ≤2 d 5 (31.25%)
 >2 d 11 (68.75%)
 Reintervention 0 (0%) 0 (0%) 0 (0%)
 Complications 0 (0%) 0 (0%) 0 (0%)
 Mortality 0 (0%) 0 (0%) 0 (0%)
 Medications
 Clopidogrel 13 (81.25%) 13 (81.25%) 13 (81.25%)
 Anticoagulant (warfarin/apixaban) 3 (18.75%) 3 (18.75%) 3 (18.75%)
Echocardiographic outcome
 MR severity across the defect
 No/trivial 16 (100%) 16 (100%) 16 (100%)
 Mild (I) 0 (0%) 0 (0%) 0 (0%)
 Moderate (II) 0 (0%) 0 (0%) 0 (0%)
 Severe (III) 16 (100%) 0 (0%) 0 (0%) 0 (0%)
 MV Pg (mmHg) 3.42 ± 0.84 4.00 ± 1.07 (p = 0.17) 4.38 ± 1.46 (p = 0.09) 4.57 ± 1.41 (p = 0.07)
 TR severity
 None/trivial 0 (0%) 0 (0%) 0 (0%) 0 (0%)
 Mild (I) 6 (37.5%) 10 (62.5%) 10 (62.5%) 10 (62.5%)
 Moderate (II) 8 (50%) 6 (37.5%) 6 (37.5%) 6 (37.5%)
 Sever (III) 2 (12.5%) 0 (0%) 0 (0%) 0 (0%)
 eSPAP (mmHg) 41.0 ± 11.1 38.13 ± 9.8 (p = 0.006∗) 32.88 ± 5.79 (p = 0.016∗) 32.25 ± 5.12 (p = 0.015∗)
 LVOT Pg (mmHg) 1.93 ± 1.33 2.3 ± 1.8 (p = 0.2) 2.13 ± 1.89 (p = 0.49) 2.19 ± 1.77 (p = 0.45)
 LVEF (%) 47.38 ± 10.97 48.63 ± 10.93 (p = 0.06) 51.13 ± 9.69 (p = 0.027) 51.25 ± 10.01 (p = 0.054)
 PVF (S/D ratio)
 Decreased S wave, S/D ratio <1 12 (75%)
 Blunted S wave, S/D ratio <1 4 (25%)
 Normal S/D ratio >1 0 (0%) 16 (100%) 16 (100%) 16 (100%)

eSPAP, estimated systolic pulmonary artery pressure; ICU, intensive care unit; LAP, left atrial pressure; LVEF, left ventricle ejection fraction; LVOT, left ventricular outflow tract; MR, mitral regurge; MV, mitral valve; NYHA-FC, New York Heart Association Functional Class; Pg, pressure gradient; PVF, pulmonary venous flow; S/D, pulmonary venous systolic/diastolic flow; TR, tricuspid regurge.